Actively Recruiting

Phase Not Applicable
Age: 12Years - 22Years
All Genders
NCT07554755

TIS for NSSI in Adolescent Depression

Led by The Second Hospital of Anhui Medical University · Updated on 2026-04-28

60

Participants Needed

1

Research Sites

39 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Temporal Interference Stimulation (TIS) has been successfully used to help patients with depression. However, its role in alleviating self injuries remained uncertain. This trial will compare the effectiveness of TIS to a placebo control on non-suicidal self injury (NSSI) in patients with major depressive disorder(MDD).

CONDITIONS

Official Title

TIS for NSSI in Adolescent Depression

Who Can Participate

Age: 12Years - 22Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Meet the DSM-5 criteria for major depressive disorder
  • Be aged 12 to 22 years with at least one guardian to monitor for 3 months
  • Have a Hamilton Rating Scale for Depression (HAMD-17) total score of 18 or higher
  • Have two or more non-suicidal self-injury behaviors meeting DSM-5 criteria within 2 weeks before admission
  • Have had NSSI behavior on more than 5 days in the past year
  • Provide informed consent from patient and guardian
Not Eligible

You will not qualify if you...

  • Abuse of psychoactive drugs or alcohol
  • Severe physical disability preventing follow-up completion
  • Diagnosis of other major mental illnesses like bipolar disorder, schizophrenia, mental retardation, dementia, severe cognitive impairment, or ADHD
  • Presence of severe physical disease, neurological disease, or traumatic brain injury affecting brain structure or function
  • Inability to read, understand, complete assessments, or cooperate with investigators
  • Presence of implants such as pacemakers, metal, or magnetic objects unsuitable for TIS
  • Receipt of systematic psychotherapy or transcranial magnetic stimulation within 3 months before baseline
  • Other examination abnormalities deemed inappropriate by investigators

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The Second Affiliated Hospital of Anhui Medical University

Hefei, Anhui, China, 230022

Actively Recruiting

Loading map...

Research Team

Y

Yanghua Tian, PhD

CONTACT

H

Hongping Wang

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here